Evaluation of antioxidant activity and acute toxicity of clausena excavata leaves extract

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Albaayit, Shaymaa Fadhel Abbas ^a,b   Abba, Yusuf ^c   Abdullah, Rasedee ^c   Abdullah, Noorlidah ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF BAGHDAD   (Iraq)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ALANINE AMINOTRANSFERASE; ALUMINUM CHLORIDE; ASPARTATE AMINOTRANSFERASE; CHLOROFORM; CLAUSENA EXCAVATA EXTRACT; FLAVONOID; HEMOGLOBIN; METHANOL; PETROLEUM ETHER; PHENOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASSAY; BOWMAN CAPSULE; CLAUSENA EXCAVATA; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; ERYTHROCYTE COUNT; FEMALE; FERRIC REDUCING ANTIOXIDANT POWER ASSAY; HEALTH PROMOTION; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; IN VITRO STUDY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY MASS; LEUKOCYTE COUNT; LIVER DISEASE; LIVER FUNCTION TEST; LIVER WEIGHT; LYMPHOCYTIC INFILTRATION; MALE; MORTALITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERILOBULAR NECROSIS; PHYTOCHEMISTRY; PLANT LEAF; RAT; RUTACEAE; SOLVENT EXTRACTION; TUBULAR EPITHELIAL DEGENERATION;

EID: 84920506874     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/975450     Document Type: Article

References (28)

1. S. Ehara, M. Ueda, T. Naruko et al., "Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases," Journal of Diabetes and Its Complications, vol. 16, no. 1, pp. 60-64, 2002.
2. S. Mitra, A. Deshmukh, R. Sachdeva, J. Lu, and J. L. Mehta, "Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy," American Journal of the Medical Sciences, vol. 342, no. 2, pp. 135-142, 2011.
3. O. Tricot, Z. Mallat, C. Heymes, J. Belmin, G. Lesèche, and A. Tedgui, "Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques," Circulation, vol. 101, no. 21, pp. 2450-2453, 2000.
4. Y. J. Geng, "Biologic effect and molecular regulation of vascular apoptosis in atherosclerosis," Current Atherosclerosis Reports, vol. 3, no. 3, pp. 234-242, 2001.
5. J. Lu, S. Mitra, X. Wang, M. Khaidakov, and J. L. Mehta, "Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis," AntioxidantsandRedox Signaling, vol. 15, no. 8, pp. 2301-2333, 2011.
6. T. Imanishi, T. Hano, T. Sawamura, S. Takarada, and I. Nishio, "Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells," Circulation Journal, vol. 66, no. 11, pp. 1060-1064, 2002.
7. C. Mazière and J.-C. Mazière, "Activation of transcription factors and gene expression by oxidized low-density lipoprotein," Free Radical Biology and Medicine, vol. 46, no. 2, pp. 127-137, 2009.
8. D. Li and J. L. Mehta, "Intracellular signaling of LOX-1 in endothelial cell apoptosis," Circulation Research, vol. 104, no. 5, pp. 566-568, 2009.
9. S. Murakami, W. Li, M. Matsuura, T. Satou, S. Hayashi, and K. Koike, "Composition and seasonal variation of essential oil in Alpinia zerumbet from Okinawa Island," Journal of Natural Medicines, vol. 63, no. 2, pp. 204-208, 2009.
10. C.-M. Chuang, H.-E. Wang, C.-C. Peng, K. C. Chen, and R. Y. Peng, "Hypolipidemic effects of different angiocarp parts of Alpinia zerumbet," Pharmaceutical Biology, vol. 49, no. 12, pp. 1257-1264, 2011.
11. X. C. Shen, H. S. Hu, and H. T. Xiao, "GC-MS analysis of chemical constituents of the essential oil from different partsof Alpinia zerumbet (Pers.) Burtt et Smith," Chinese Journal of Pharmaceutical Analysis, vol. 30, no. 8, pp. 1399-1403, 2010.
12. X.-C. Shen, L. Tao, W.-K. Li, Y.-Y. Zhang, H. Luo, and Y.-Y. Xia, "Evidence-based antioxidant activity of the essential oil from Fructus A. zerumbet on cultured human umbilical vein endothelial cells injury induced by ox-LDL," BMC Complementary and Alternative Medicine, vol. 12, article 174, 2012.
13. L. Tao, H. S. Hu, and X. C. Shen, "Endothelium-dependent vasodilatation effects of the essential oil from Fructus alpiniae zerumbet (EOFAZ) on rat thoracic aortic rings in vitro," Phytomedicine, vol. 20, no. 5, pp. 387-393, 2013.
14. X. C. Jiang and J. Liu, "Sphingolipidmetabolism and atherosclerosis," in Sphingolipids in Disease, vol. 216 of Handbook of experimental pharmacology, pp. 133-146, Springer, Vienna, Austria, 2013.
15. L. Tao, T. T. Xiao, H. S. Hu, L. Tu, and X. D. Liu, "Effects of volatile oils from fructus Alpiniae zerumber on the contraction of rabbit thoracic aorta in vitro," Chinese Journal of Hospital Pharmacy, vol. 30, no. 23, pp. 1966-1969, 2010.
16. L. Tao, X. C. Shen, J. Peng, and S. Bo, "Experimental study on the anti-inflammatory and analgesic effects in vivo of essential oil from frucus Alpiniae zerumbet in mice," Chinese Journal of Hospital Pharmacy, vol. 30, no. 9, pp. 722-724, 2010.
17. D. Onat,D. Brillon, P. C.Colombo, and A. M. Schmidt, "Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis," Current Diabetes Reports, vol. 11, no. 3, pp. 193-202, 2011.
18. S. Tsimikas and Y. I.Miller, "Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease," Current Pharmaceutical Design, vol. 17, no. 1, pp. 27-37, 2011.
19. H. Cai and D. G. Harrison, "Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress," Circulation Research, vol. 87, no. 10, pp. 840-844, 2000.
20. H. M. Berens and K. L. Tyler, "The proapoptotic Bcl-2 protein bax plays an important role in the pathogenesis of reovirus encephalitis," Journal of Virology, vol. 85, no. 8, pp. 3858-3871, 2011.
21. H. Kataoka, N. Kume, S. Miyamoto et al., "Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-
22. in vascular smooth muscle cells," Arteriosclerosis,Thrombosis, and Vascular Biology, vol. 21, no. 6, pp. 955-960, 2001.
23. F. de Nigris, L. Gallo, V. Sica, and C. Napoli, "Glycoxidation of low-density lipoprotein promotes multiple apoptotic pathways and NFB activation in human coronary cells," Basic Research in Cardiology, vol. 101, no. 2, pp. 101-108, 2006.
24. C.-Y.Wu, Z.-H. Tang, L. Jiang, X.-F. Li, Z.-S. Jiang, and L.-S. Liu, "PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax-caspase9-caspase3 pathway,"Molecular andCellular Biochemistry, vol. 359, no. 1-2, pp. 347-358, 2012.
25. A. B. Sanz, B. Santamaría, M. Ruiz-Ortega, J. Egido, and A. Ortiz, "Mechanisms of renal apoptosis in health and disease," Journal of the American Society of Nephrology, vol. 19, no. 9, pp. 1634-1642, 2008.
26. Y. Zhang,N. Chen, J. Zhang, and Y. Tong, "Hsa-Let-7gmiRNA targets caspase-3 and inhibits the apoptosis induced by ox-LDL in endothelial cells," International Journal ofMolecular Sciences, vol. 14, no. 11, pp. 22708-22720, 2013.
27. Z.-B. Wang, Y.-Q. Liu, and Y.-F. Cui, "Pathways to caspase activation," Cell Biology International, vol. 29,no. 7, pp.489-496, 2005.
28. J. Chen, J. L. Mehta, N. Haider, X. Zhang, J. Narula, and D. Li, "Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells," Circulation Research, vol. 94, no. 3, pp. 370-376, 2004.